CTK’s OnSite COVID-19 IgG/IgM Rapid Test’s performance in detecting antibody responses following COVID-19 vaccination was evaluated in a cohort of 20 subjects that had no detectable levels of anti-SARS-CoV-2 antibodies before vaccination.
All 20 subjects (100%) had their first positive result on the OnSite COVID-19 IgG/IgM Rapid Test 9 to 16 days post-vaccination, showing this test’s high sensitivity.
Our ongoing study’s preliminary data shows that the OnSite COVID-19 IgG/IgM Rapid Test can detect the antibody response induced by COVID-19 vaccination with high accuracy.
Results will be updated as more subjects are vaccinated and receive the second vaccine dose.
To read the white paper, click here
Lewis, S, Zhang, L, Zhang, B, Lorenzo, L, Liberal V. (2020). Ongoing studies indicate that CTK’s OnSite Covid-19 IgG/IgM Rapid Tests detect antibodies in response to COVID-19 vaccines and neutralizing antibodies produced after Sars-Cov-2 exposure or vaccination [White paper]. CTK Biotech.